U.S. markets open in 8 hours 52 minutes

Aptorum Group Limited (APM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.2400-0.0500 (-3.88%)
At close: 04:00PM EDT
1.3300 +0.09 (+7.26%)
After hours: 05:48PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.2900
Bid0.0000 x 800
Ask0.0000 x 1000
Day's Range1.2100 - 1.2900
52 Week Range0.8550 - 2.7200
Avg. Volume124,934
Market Cap44.272M
Beta (5Y Monthly)0.03
PE Ratio (TTM)N/A
EPS (TTM)-0.7150
Earnings DateApr 29, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for APM

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Aptorum Group Limited
    Daily – Vickers Top Buyers & Sellers for 04/19/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    5 months agoArgus Research
View more

    Aptorum Group Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

    RedChip Companies will air an interview on Aptorum Group Limited (NASDAQ:APM)(Euronext Paris:APM), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, on The RedChip Money Report® on Bloomberg TV, this Saturday, September 24, at 7 p.m. Eastern Time (ET).

  • Benzinga

    Aptorum Highlights Updates On Clinical Validation of RPIDD Infectious Disease Molecular Diagnostics

    Aptorum Group Limited (NASDAQ: APM) announced further updates on the analytical, retrospective, and prospective clinical validation of the RPIDD technology in patient samples employed under Illumina iSeq 100 and MiniSeq sequencing platforms. RPIDD, using its proprietary developed depletion and enrichment technologies, has been clinically validated in over 100 patient samples. In the completed retrospective clinical validation, both iSeq 100 and MiniSeq employing the RPIDD workflow demonstrated 1

  • Business Wire

    Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in Hong Kong

    NEW YORK & LONDON & PARIS, September 15, 2022--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group"), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to tackling unmet medical needs, announces the commercial launch of NativusWell®, a new dietary supplement supporting women’s health throughout the Menopausal period. NativusWell® is distributed via HKTV Mall and NativusWell® official website